Comprehensive clinical cancer analysis of homologous recombination…
Combining tissue and blood biopsies reveals which patients are developing resistance to cancer drugs, enabling faster switches to alternative treatments.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Detection of early-stage lung adenocarcinoma using a novel…
A blood test using four cancer markers shows promise for catching early lung cancer, with accuracy improving as tumors grow larger.
Novel or significantly improved treatmentQuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly…
A global trial will test whether a drug already helping certain leukemia patients might extend survival in a leukemia type with few treatment options.
Novel or significantly improved treatmentDual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of…
New engineered immune cells targeting two proteins simultaneously show stronger activity against leukemic stem cells with minimal harm to healthy blood cells.
Near-term implementable findingFUO-PETMamba: a pet maximum-intensity-projection-based artificial…
An AI tool learns to distinguish fever causes on PET scans, potentially helping doctors diagnose cancers and infections more accurately and consistently.